Clinical Trials in New York State

Showing 5321-5340 of 17,167 trials

A Study of AK117 in Combination With Azacitidine in Patients With Myelodysplastic Syndromes

NCT06196203

This is a Phase 2 randomized, double-blind, placebo-controlled, multicenter study evaluating the efficacy and safety of AK117 or placebo, combined with azacitidine in patients with newly diagnosed higher-risk myelodysplastic syndromes (HR-MDS).

Higher-risk Myelodysplastic Syndromes

Akeso90 participantsStarted Feb 2024

Los Angeles, California, United States • Aurora, Colorado, United States • New Haven, Connecticut, United States +12 more locations

TERMINATEDPhase 1112 miles

(Concerto) Study of BLU-451 in Advanced Cancers With EGFR Exon 20 Insertion Mutations

NCT05241873

This is a Phase 1/2, open-label first-in-human study of the safety, pharmacokinetics (PK), pharmacodynamics, and anti-tumor activity of BLU-451 monotherapy and BLU-451 in combination with platinum-based chemotherapy (carboplatin and pemetrexed). All participants will receive BLU-451 on a 21-day treatment cycle.

Lung Neoplasm MalignantCarcinoma, Non-Small-Cell LungRespiratory Tract Neoplasms+17 more

Blueprint Medicines Corporation103 participantsStarted Mar 2022

Duarte, California, United States • Los Angeles, California, United States • Aurora, Colorado, United States +20 more locations

A Study of AK117 in Combination With Azacitidine in Patients With Myelodysplastic Syndromes

(Concerto) Study of BLU-451 in Advanced Cancers With EGFR Exon 20 Insertion Mutations

Find Trials by Condition in New York State

A Follow up Study of Patients Treated With Imlifidase Prior to Kidney Transplantation

A Study of Participants with Β-Thalassemia Treated with Betibeglogene Autotemcel

A Study of SGN-ALPV in Advanced Solid Tumors

A Trial of a Novel XPO1 Inhibitor in Participants With Advanced Solid Tumors

Evaluation of SAR408701 in Patients With Advanced Solid Tumors

Study to Evaluate the Safety of CG-P5 Peptide Eye Drops in Patients Diagnosed With Age-related Wet Macular Degeneration

Study on BI 54903 (Inhaled Corticosteroid) Administered Twice Daily Via Respimat Inhaler in Patients With Asthma Inadequately Controlled on Medium Dose Inhaled Corticosteroid (ICS).

Surveillance and Alert-based Multiparameter Monitoring to Reduce Worsening Heart Failure Events

NB-001 in Children and Adolescents With 22q11 Deletion Syndrome

A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Upadacitinib in Pediatric Participants With Severe Atopic Dermatitis

A Food Additive Removal Diet for Pediatric Eosinophilic Esophagitis

A Study of ERAS-007 in Patients With Advanced Gastrointestinal Malignancies

A Study of the Safety and Tolerability in Participants With PIK3CA-related Overgrowth Spectrum or Proteus Syndrome Who Are Being Treated With Miransertib (MK-7075) in Other Studies (MK-7075-006)

LDK378 Versus Chemotherapy in ALK Rearranged (ALK Positive) Patients Previously Treated With Chemotherapy (Platinum Doublet) and Crizotinib

Non-comparative Study of IFX-1 Alone or IFX-1+Pembrolizumab in Patients With Locally Advanced or Metastatic cSCC.

Futibatinib Versus Gemcitabine-Cisplatin Chemotherapy as First-Line Treatment of Patients With Advanced Cholangiocarcinoma Harboring FGFR2 Gene Rearrangements

A Study of Imvotamab in Severe Systemic Lupus Erythematosus

Foot and Ankle Post-operative Oedema Management Using Geko™